COPENHAGEN – The Danish crown weakened on Friday after disappointing results from a late-stage trial of a new weight-loss drug […]
Novo Nordisk’s Drug Trial Results Weaken Danish Currency Read More »
LONDON/COPENHAGEN – On Friday, Novo Nordisk (NYSE: NVO) revealed disappointing results in a late-stage trial for its experimental next-generation obesity
LONDON/COPENHAGEN – On Friday, Novo Nordisk (NYSE: NVO) shareholders sought to find out why such a high number of patients
Novo Nordisk’s Dosing in CagriSema Obesity Drug Trial Puzzles Investors Read More »
SHANGHAI – As Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) expand sales of their popular diabetes and weight-loss
In Weight Loss Battle, Novo and Lilly Face Growing Offensive from Licensed Copies Read More »
STOCKHOLM/LONDON – Novo Nordisk (NYSE: NVO), the Danish drugmaker, will invest 8.5 billion crowns ($1.20 billion) in a new facility
Novo Nordisk to Invest $1.2 Billion in New Rare Disease Drugs Plant in Denmark Read More »
LONDON – Britons paying privately for obesity drugs are increasingly choosing Eli Lilly’s (NYSE: LLY) Mounjaro over Novo Nordisk’s (NYSE:
Lilly’s Mounjaro Gains Market Share Over Wegovy in UK’s Private Obesity Drug Market Read More »
On Wednesday, Novavax (NASDAQ: NVAX), the U.S.-based vaccine maker, said it would sell its manufacturing facility in the Czech Republic
Novavax to Sell Czech Manufacturing Unit to Novo Nordisk for $200 Million Read More »
COPENHAGEN – Shares of weight-loss drug makers Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) rose on Tuesday after
Novo, Lilly Shares Rise as Biden Proposes Obesity Care Coverage Read More »
More than 200,000 prescriptions for copies of Novo Nordisk’s (NYSE: NVO) weight-loss drug Wegovy are getting filled by U.S. patients
Exclusive: Thousands Turn to Wegovy Copies Each Month as FDA Considers Shortage Status Read More »
Copyright © 2024 abbonews.com
